The Rwandan government, Merck, and Qiagen have started a national cervical cancer prevention program in the African country, the first nation on the continent to do so, reports Science Insider's Martin Enserink. Merck and Qiagen will make donations to help vaccinate girls against HPV, and Merck will donate more than two million doses of its HPV vaccine Gardasil for the first three years of the program, which is targeting girls ages 12 to 15, Enserink says.
Help for Rwanda
Premium
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.